Insider Transactions Reported by 9 Insiders of Unicycive Therapeutics, Inc.

Symbol
UNCY on Nasdaq
Location
Los Altos, CA

There are no Buy or Sell transactions made by insiders since 12 Mar 2025

Unicycive Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Gaurav Aggarwal Director $8,430,499 25 Aug 2025
Pramod Gupta EVP, Pharmaceuticals and BD 28 Jul 2025
Shalabh K. Gupta CEO, Director 28 Jul 2025
John L. Ryan Director 05 Sep 2023
Sara Kenkare-Mitra Director 28 Jul 2025
John Townsend Chief Financial Officer 28 Jul 2025
Douglas Jermasek EVP of Corporate Strategy 28 Jul 2025
Brigitte Schiller Director 15 Jul 2022
Sandeep Laumas Director 28 Jul 2025

Recent Insider Transactions by Companies or Individuals for Unicycive Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.